Cardinal Health expands Actinium-225 production capacity to support growing demand for novel cancer therapies
Go back to Cardinal Health expands Actinium-225 production capacity to support growing demand for novel cancer therapies| Cardinal Health Inc. (NYSE: CAH) | Delayed: 225.38 +2.64 (1.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $222.74 | 52 Week High | $91.22 | |||
| Open | $225.21 | 52 Week Low | $62.70 | |||
| Day High | $226.08 | P/E | 210.64 | |||
| Day Low | $222.50 | EPS | $1.07 | |||
| Volume | 258,043 | |||||
